Josephine E. Baker

300 Grattan Street
Parkville, NSW 3050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort study.

The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort study.

Journal: Journal of neurology

Published: August 04, 2025

CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study.

CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study.

Journal: Clinical immunology (Orlando, Fla.)

Published: April 26, 2024

Twelve-month efficacy of CGRP monoclonal antibodies and predictive value of short-term response: results of an Australian multicentre study.

Twelve-month efficacy of CGRP monoclonal antibodies and predictive value of short-term response: results of an Australian multicentre study.

Journal: BMJ neurology open

Published: September 27, 2023

The short-term effects of CGRP monoclonal antibodies on bone turnover: A prospective cohort study.

The short-term effects of CGRP monoclonal antibodies on bone turnover: A prospective cohort study.

Journal: Cephalalgia : an international journal of headache

Published: June 02, 2023

Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.

Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.

Journal: CNS drugs

Published: March 25, 2021

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients.

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients.

Journal: Therapeutic advances in neurological disorders

Published: January 10, 2021

Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic.

Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic.

Journal: Multiple sclerosis and related disorders

Published: October 10, 2020

Association of Pregnancy With the Onset of Clinically Isolated Syndrome.

Association of Pregnancy With the Onset of Clinically Isolated Syndrome.

Journal: JAMA neurology

Published: September 14, 2020

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.

Journal: Multiple sclerosis and related disorders

Published: July 16, 2020

Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells.

Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells.

Journal: Life science alliance

Published: January 20, 2020

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

Journal: Neurology

Published: October 26, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026